Compare A & RJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | A | RJF |
|---|---|---|
| Founded | 1999 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Bankers/Brokers/Service |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.0B | 33.5B |
| IPO Year | 1999 | 2005 |
| Metric | A | RJF |
|---|---|---|
| Price | $160.27 | $175.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 12 |
| Target Price | $161.47 | ★ $174.67 |
| AVG Volume (30 Days) | ★ 1.3M | 946.7K |
| Earning Date | 05-27-2026 | 04-22-2026 |
| Dividend Yield | 0.92% | ★ 1.39% |
| EPS Growth | 3.16 | ★ 6.19 |
| EPS | 2.27 | ★ 8.52 |
| Revenue | $4,472,000,000.00 | ★ $15,912,000,000.00 |
| Revenue This Year | $8.45 | $13.28 |
| Revenue Next Year | $6.13 | $7.76 |
| P/E Ratio | $68.86 | ★ $20.23 |
| Revenue Growth | 6.43 | ★ 6.63 |
| 52 Week Low | $108.35 | $138.82 |
| 52 Week High | $160.27 | $182.73 |
| Indicator | A | RJF |
|---|---|---|
| Relative Strength Index (RSI) | 81.24 | 52.33 |
| Support Level | $135.76 | $175.02 |
| Resistance Level | $160.27 | $182.73 |
| Average True Range (ATR) | 3.68 | 3.33 |
| MACD | 1.10 | -1.17 |
| Stochastic Oscillator | 98.83 | 35.17 |
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Raymond James Financial is a diversified financial services firm that provides wealth management, investment banking, asset management, and capital markets services to individuals, corporations, and municipalities. The firm maintains an extensive catalogue of products and services across its business lines. However, the wealth management franchise generates the bulk of its revenues and earnings through a vast network of more than 8,900 independent and employee-affiliated advisors, who collectively managed over $1.7 trillion in client assets as of fiscal year-end 2025. While Raymond James maintains a global footprint, the company derives over 90% of its revenue and an even larger percentage of its operating income, from the United States.